Daily SPAC Update – February 3, 2025

by | Feb 3, 2025

Maquia Capital (MAQC) Extension Approved. GLST + K Enter Holdings Merger Vote. Broad Capital (BRAC) Sets Deal Vote. DRDB and MLAC Separate Trading.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
MAQC – MAQUIA CAPITAL ACQUISITION CORP * Extend to Feb 07, 2026 * 76,516 redeemed

MERGER VOTES
GLST – Global Star Acquisition Inc + K Enter Holdings Inc.
K Enter Holdings Inc. is a recently formed holding company for the purpose of acquiring seven diversified entertainment operating companies based in Korea, engaged in the entertainment content and IP creation businesses (the “Seven Korean Entities”). K Enter has an internal K drama production team, and the Seven Korean Entities to be acquired by K Enter include Solaire Partners Ltd. (“Solaire Partners”), a Korean content-specialized private equity firm based in Seoul Korea that has invested in some of the highest-grossing films out of Korea, one K drama production company, three K movie production companies, one virtual production company, and one IP merchandising company. As a combined platform, we expect these companies to provide a significant amount of synergy.

SPAC DEAL & EXTENSION VOTES SET
BRAC – Broad Capital Acquisition Corp * DEAL VOTE SET: Feb 21, 2025 * trust $11.89

SEPARATE WARRANTS/RIGHTS
Feb 06: HENNESSY CAPITAL INVESTMENT CORP VII (HVII)
Feb 03: ROMAN DBDR ACQUISITION CORP II (DRDB)
Feb 03: MOUNTAIN LAKE ACQUISITION CORP (MLAC)

YESTERDAY’S TOP SPAC GAINERS
9.66% ~ $ 12.94 | PWUP – POWERUP ACQUISITION CORP (Announced)
3.94% ~ $ 13.20 | IPXX – INFLECTION POINT ACQUISITION CORP II (Announced)
3.14% ~ $ 12.50 | TETE – TECHNOLOGY & TELECOMMUNICATION ACQUISITION CORP (Announced)
1.70% ~ $ 11.35 | GBBK – GLOBAL BLOCKCHAIN ACQUISITION CORP (Announced)
1.39% ~ $ 5.84 | RFAC – RF ACQUISITION CORP (Announced)

YESTERDAY’S TOP SPAC LOSERS
-39.10% ~ $ 8.83 | GLST – GLOBAL STAR ACQUISITION INC (Announced)
-11.52% ~ $ 9.75 | WAVS – WESTERN ACQUISITION VENTURES CORP (Announced)
-10.87% ~ $ 11.81 | AIMAU – AIMFINITY INVESTMENT CORP I (Announced)
-8.93% ~ $ 6.12 | BOWN – BOWEN ACQUISITION CORP (Announced)
-2.58% ~ $ 11.69 | CSLM – CSLM ACQUISITION CORP (Announced)

LATEST SPAC IPO PERFORMANCE
Jan 29 | | SVCC – Stellar V Capital Corp.
Jan 28 |  | FGMC – FG Merger II Corp.
Jan 27 |  | DMAA – Drugs Made In America Acquisition Corp.
Jan 21 | $ 10.05 | COLA – Columbus Acquisition Corp
Jan 16 | $ 10.03 | HVII – Hennessy Capital Investment Corp. VII
Jan 14 | $ 10.08 | RIBB – Ribbon Acquisition Corp.
Jan 14 | $ 10.04 | PLMK – Plum Acquisition Corp, IV
Jan 07 | $ 10.05 | CEPO – Cantor Equity Partners I, Inc.

Recent Analysis

Weekly Boardroom & Executive Moves: May 1, 2026

This week, significant leadership changes occurred across several companies facing financial difficulties. Abbott Laboratories (ABT) and Agilon Health Inc (AGL) appointed new board members and executives amidst high activist risks and declining TSRs. Accuray Inc (ARAY) and ALT5 Sigma Corp (ALTS) also saw key executive departures and appointments as they navigate substantial TSR declines. These shifts highlight the ongoing challenges and strategic redirections needed to stabilize operations and improve shareholder value.

Daily SPAC Update – May 1, 2026

Two SPAC IPOs launched today, raising a total of $500 million. CH4 Natural Solutions Acquisition Corp (MTNE) secured $300 million, while Quantum Leap Acquisition Corp (QLEP) raised $200 million. Today, 2 SPAC IPOs raised $500M, led by CH4 Natural Solutions (MTNE) at $300M. This follows a surge of activity at the end of April.

Daily SPAC Update – April 30, 2026

Today, six SPACs debuted, raising a total of $965 million. General Catalyst Global Resilience Merger Corp (GCGR) led the pack with $350 million, followed by RRE Ventures Acquisition Corp. (RREV) at $250 million. Month-to-date, SPAC IPOs total 16, bringing in $2.65 billion, compared to 11 IPOs last month that raised $1.72 billion.

Daily SPAC Update – April 29, 2026

Collective Acquisition Corp. II (CAII) launched its $220 million IPO today, targeting high-potential sectors like technology and healthcare. In executive moves, Roger Bendelac was appointed CEO of both Drugs Made in America Acquisition Corp (DMAA) and Drugs Made in America Acquisition II Corp (DMII), with Saleem Elmasri as CFO. Meanwhile, General Purpose Acquisition Corp (GPAC) saw a significant decline of 22.9%, closing at $9.96, while Aimei Health Technology Co Ltd (AFJK) gained 2.7% to $46.12.

Daily SPAC Update – April 28, 2026

SPAC IPOs Look Stalled Again as Irenic’s $220M IPO Only Makes it Seven. Miluna Acquisition + CADV.AI Deal. Prophyte Extension Vote to Add 12 More Months.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.